MX2022015792A - Composiciones farmaceuticas topicas. - Google Patents
Composiciones farmaceuticas topicas.Info
- Publication number
- MX2022015792A MX2022015792A MX2022015792A MX2022015792A MX2022015792A MX 2022015792 A MX2022015792 A MX 2022015792A MX 2022015792 A MX2022015792 A MX 2022015792A MX 2022015792 A MX2022015792 A MX 2022015792A MX 2022015792 A MX2022015792 A MX 2022015792A
- Authority
- MX
- Mexico
- Prior art keywords
- topical pharmaceutical
- pharmaceutical compositions
- patient
- relates
- oil phase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a composiciones de emulsión farmacéuticas tópicas que comprenden una cantidad terapéuticamente eficaz de 3,5-dihidroxi-4-isopropil-trans-estilbe no o una sal farmacéuticamente aceptable del mismo, una fase oleosa, una fase acuosa, un agente tensioactivo y un antioxidante, y en donde la composición de emulsión es homogénea y/o el principio activo se solubiliza en la fase oleosa. La invención también se refiere a métodos para tratar una condición o trastorno dermatológico en un paciente mediante la administración de las presentes composiciones a la piel del paciente.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063043360P | 2020-06-24 | 2020-06-24 | |
| US202063043340P | 2020-06-24 | 2020-06-24 | |
| PCT/US2021/038794 WO2021262917A1 (en) | 2020-06-24 | 2021-06-24 | Topical pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022015792A true MX2022015792A (es) | 2023-02-27 |
Family
ID=79281807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022015792A MX2022015792A (es) | 2020-06-24 | 2021-06-24 | Composiciones farmaceuticas topicas. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230225987A1 (es) |
| EP (1) | EP4171529A4 (es) |
| JP (1) | JP2023531489A (es) |
| KR (1) | KR20230026497A (es) |
| AU (1) | AU2021296867A1 (es) |
| CA (1) | CA3183195A1 (es) |
| IL (1) | IL298827A (es) |
| MX (1) | MX2022015792A (es) |
| WO (1) | WO2021262917A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024254228A1 (en) * | 2023-06-06 | 2024-12-12 | LifeActive, Inc. | Transdermal delivery formulations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9215354D0 (en) * | 1992-07-20 | 1992-09-02 | Unilever Plc | Cosmetic composition |
| US9925153B2 (en) * | 2013-12-06 | 2018-03-27 | Stc.Unm | Therapeutic agents for skin diseases and conditions |
| PT3297605T (pt) * | 2015-05-21 | 2022-05-30 | Dermavant Sciences GmbH | Composições farmacêuticas tópicas |
| US11617724B2 (en) * | 2015-05-21 | 2023-04-04 | Dermavant Sciences GmbH | Topical pharmaceutical compositions |
| US20200147000A1 (en) * | 2018-11-13 | 2020-05-14 | Dermavant Sciences GmbH | Use of tapinarof for the treatment of chronic plaque psoriasis |
| US11497718B2 (en) * | 2018-11-13 | 2022-11-15 | Dermavant Sciences GmbH | Use of tapinarof for the treatment of atopic dermatitis |
-
2021
- 2021-06-24 KR KR1020237002658A patent/KR20230026497A/ko active Pending
- 2021-06-24 IL IL298827A patent/IL298827A/en unknown
- 2021-06-24 AU AU2021296867A patent/AU2021296867A1/en active Pending
- 2021-06-24 US US18/002,511 patent/US20230225987A1/en active Pending
- 2021-06-24 EP EP21829794.3A patent/EP4171529A4/en active Pending
- 2021-06-24 WO PCT/US2021/038794 patent/WO2021262917A1/en not_active Ceased
- 2021-06-24 MX MX2022015792A patent/MX2022015792A/es unknown
- 2021-06-24 JP JP2022578951A patent/JP2023531489A/ja active Pending
- 2021-06-24 CA CA3183195A patent/CA3183195A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021262917A1 (en) | 2021-12-30 |
| AU2021296867A1 (en) | 2023-01-19 |
| IL298827A (en) | 2023-02-01 |
| JP2023531489A (ja) | 2023-07-24 |
| EP4171529A4 (en) | 2024-05-01 |
| US20230225987A1 (en) | 2023-07-20 |
| EP4171529A1 (en) | 2023-05-03 |
| CA3183195A1 (en) | 2021-12-30 |
| KR20230026497A (ko) | 2023-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| MX2020010907A (es) | Mejora de suministro de agentes activos lipofilicos a traves de la barrera hematoencefalica y metodos para tratar trastornos del sistema nervioso central. | |
| JP2016515525A5 (es) | ||
| CN111372595A (zh) | 治疗皮肤的方法和组合物 | |
| BR112021025701A2 (pt) | Formulações e métodos de parasiticida de isoxazolina para tratar blefarite | |
| CN103347507A (zh) | 用于治疗痤疮的褪黑激素以及抗微生物剂或抗菌剂 | |
| MX2022015792A (es) | Composiciones farmaceuticas topicas. | |
| US20140350106A1 (en) | Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same | |
| EA025135B1 (ru) | Косметическая и/или фармацевтическая композиция для лечения воспаления кожи и связанных синдромов | |
| BR102017003313B1 (pt) | Composição anticaspa e método para a prevenção, redução ou tratamento da caspa | |
| RU2017140078A (ru) | Косметический способ и его терапевтическое применение для уменьшения объема жировой ткани | |
| KR20230139402A (ko) | 염증성 피부 증후군을 치료하는 약제학적인 용도의 화장품 조성물 | |
| JP7299683B2 (ja) | 皮膚外用組成物 | |
| JP2015081244A (ja) | ニキビ治療用医薬組成物 | |
| HUE028120T2 (en) | Compositions for the treatment of peripheral ulcers of various origins | |
| US20080076831A1 (en) | Hemorrhoid reliever and method of use | |
| CN110944649B (zh) | 鼠李糖及其衍生物作为抗真菌剂的用途 | |
| MX2023009424A (es) | Composicion antitranspirante. | |
| JP7299682B2 (ja) | 皮膚外用組成物 | |
| JP7329910B2 (ja) | 皮膚外用組成物 | |
| US20060019935A1 (en) | Composition and method for treating acne including anti-inflammatory Hepes Oleate | |
| JPH08165244A (ja) | 皮膚疾患治療剤 | |
| JP2002338476A (ja) | 腎透析に伴う痒みの予防治療剤 | |
| US20250352515A1 (en) | Topical formulations | |
| US20160089441A1 (en) | Composition for the treatment of cold sores |